A new study Levels of selected carcinogens and toxicants in vapour from electronic cigarettes from the journal Tobacco Control concludes that
substituting tobacco cigarettes with e-cigarettes may substantially reduce exposure to selected tobacco-specific toxicants. E-cigarettes as a harm reduction strategy among smokers unwilling to quit, warrants further study.
Strong words considering the source but still I would quibble that more action rather than further study is what is needed here especially in consideration of the recent statement from John Britton from the Royal College of Physicians
“If all the smokers in Britain stopped smoking cigarettes and started smoking e-cigarettes we would save 5 million deaths in people who are alive today. It’s a massive potential public health prize.”
But what stood out on this smoking machine study of 12 different brands of e-cigarettes and an inhaler was that not only were the levels of the measured toxicants 9-450 times lower than those of cigarette smoke but that they were in many cases “comparable with the trace amounts found in the reference product” (the inhaler).
In other words, in this toxicants study, e-cigarettes were indistinguishable from the medically approved pharmaceutical inhaler.
Of course the party line has been too steer clear of e-cigs which have not been evaluated for safety or quality and to stick to approved cessation aids. If the approved method or device is no different than the unapproved one is the difference then just bureaucratic?
And I cannot quite get over the fact that varenicline (Champix) remains approved (Health Canada posted a warning but still encourages you to use a substance that has resulted in suicide rather than one which to date has not resulted in any fatalities or major disease) and just recently we had the news that Pfizer was settling on over 2700 lawsuits arising from its use.
The continuing availability of, and promotion by doctors, of Champix means that the anti-nicotine activists can add “quit and die” to their demand of users to “quit or die”.
(For those interested in reading more on this study see Michael Siegel’s comments.)
Addendum (April 12) and now I see that Michael has picked up the Pfizer Champix story and run with it…see If There Were 2,700 Lawsuits Against Electronic Cigarette Manufacturers, Would E-Cigs Stay on the Market? Anti-Smoking Groups Continue to Recommend Chantix Despite 2,700 Lawsuits and in Absence of Determining Validity of Claims)